Australian funded study may pave the way for a new progressive MS treatment
May 10, 2017Australia once again is on the cutting edge of MS research. Professor Michael Pender from the University of Queensland and Professor Rajiv Khanna from QIMR Berghofer Medical Research Institute, have released encouraging preliminary results from a trial of a new treatment for progressive MS, called EBV-specific adoptive immunotherapy. To read more, click on the link below:
Australian funded study may pave the way for a new progressive MS treatment
Article courtesy of MS Research Australia www.msra.org.au